BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Genetown

  Piramal Imaging To Present New Research In PET Imaging At Society Of Nuclear Medicine And Molecular Imaging 2015 Annual Meeting

  June 8, 2015

   · 

  7 min read
• Drug Development

  Capricor Therapeutics, Inc. Announces Receipt Of FDA Clearance For The Phase I/II Study Of CAP-1002 For The Treatment Of Duchenne Muscular Dystrophy Related Cardiomyopathy

  June 8, 2015

   · 

  4 min read
• Drug Development

  Fibrocell Science, Inc. And Intrexon Corporation Announce Positive In Vitro Pre-Clinical Data For FCX-007 For The Treatment Of Recessive Dystrophic Epidermolysis Bullosa (RDEB) At European Society Of Human Genetics

  June 8, 2015

   · 

  9 min read
• Drug Development

  Chimerix Completes Targeted Enrollment For Brincidofovir Phase III SUPPRESS Trial

  June 8, 2015

   · 

  7 min read
• BioCapital

  National Cancer Institute Accepts Rexahn Pharmaceuticals, Inc.'s RX-21101 For Its Nanotechnology Characterization Laboratory’s Preclinical Characterization Program

  June 8, 2015

   · 

  5 min read
• Drug Development

  Ultragenyx Pharmaceuticals Announces Completion Of Enrollment In Phase III Study Of Recombinant Human Beta-Glucuronidase In Mucopolysaccharidosis Type 7

  June 8, 2015

   · 

  5 min read
• Business

  Molecular Health Signs Distribution Agreement With TestAnalytika For Latin American Region

  June 8, 2015

   · 

  3 min read
• Biotech Bay

  BioMarin Submits Drisapersen MAA To European Medicines Agency For The Treatment Of Duchenne Muscular Dystrophy Amenable To Exon 51 Skipping

  June 8, 2015

   · 

  7 min read
• Stempeutics Receives Japan Process Patent For Its Novel Stem Cell Drug ‘Stempeucel’

  June 8, 2015

   · 

  5 min read
• Business

  Idera Pharmaceuticals, Inc. Enters Into A Strategic Clinical Research Alliance With M. D. Anderson Cancer Center To Advance Clinical Development Of Intratumoral TLR9 Agonist In Combination With Checkpoint Inhibitors

  June 8, 2015

   · 

  6 min read